Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04578470Phase 2Unknown
Phase 2, randomised, double-blind trial (3 arms), sponsored by Changi General Hospital. Primary endpoints: Recurrence rate of Benign Paroxysmal Positional Vertigo at 2 years and Time to onset of recurrent episodes of BPPV at 2 years. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04578470.